Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 14 studies | 23% ± 7% | |
| brain | 13 studies | 32% ± 17% | |
| intestine | 6 studies | 22% ± 11% | |
| eye | 6 studies | 24% ± 12% | |
| peripheral blood | 5 studies | 24% ± 7% | |
| pancreas | 4 studies | 39% ± 19% | |
| adipose | 4 studies | 22% ± 3% | |
| uterus | 3 studies | 28% ± 12% | |
| liver | 3 studies | 37% ± 10% | |
| bone marrow | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 6653.39 | 459 / 459 | 100% | 64.45 | 1118 / 1118 |
| esophagus | 100% | 5269.26 | 1445 / 1445 | 100% | 36.92 | 183 / 183 |
| pancreas | 100% | 8835.14 | 328 / 328 | 100% | 35.45 | 178 / 178 |
| prostate | 100% | 5915.52 | 245 / 245 | 100% | 61.43 | 502 / 502 |
| uterus | 100% | 6927.06 | 170 / 170 | 100% | 38.36 | 458 / 459 |
| lung | 100% | 6665.81 | 578 / 578 | 100% | 38.01 | 1152 / 1155 |
| brain | 100% | 4048.80 | 2634 / 2642 | 100% | 43.03 | 704 / 705 |
| liver | 100% | 4511.92 | 226 / 226 | 100% | 31.95 | 404 / 406 |
| thymus | 100% | 8082.97 | 653 / 653 | 100% | 68.28 | 602 / 605 |
| ovary | 100% | 9788.12 | 180 / 180 | 99% | 26.10 | 425 / 430 |
| adrenal gland | 100% | 8257.33 | 258 / 258 | 99% | 43.31 | 227 / 230 |
| bladder | 100% | 6522.29 | 21 / 21 | 98% | 31.44 | 495 / 504 |
| stomach | 100% | 5388.17 | 359 / 359 | 98% | 33.91 | 279 / 286 |
| intestine | 100% | 5784.56 | 966 / 966 | 97% | 34.65 | 512 / 527 |
| skin | 100% | 6861.82 | 1809 / 1809 | 97% | 40.05 | 457 / 472 |
| kidney | 100% | 3369.34 | 89 / 89 | 96% | 31.15 | 861 / 901 |
| adipose | 100% | 6883.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 7754.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 19.75 | 29 / 29 |
| spleen | 100% | 4487.46 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 30.07 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.03 | 1 / 1 |
| muscle | 99% | 2859.69 | 795 / 803 | 0% | 0 | 0 / 0 |
| heart | 95% | 3811.18 | 821 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 88% | 26.54 | 70 / 80 |
| peripheral blood | 73% | 2422.94 | 681 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006620 | Biological process | post-translational protein targeting to endoplasmic reticulum membrane |
| GO_0006614 | Biological process | SRP-dependent cotranslational protein targeting to membrane |
| GO_0001889 | Biological process | liver development |
| GO_0031204 | Biological process | post-translational protein targeting to membrane, translocation |
| GO_0006612 | Biological process | protein targeting to membrane |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0031207 | Cellular component | Sec62/Sec63 complex |
| GO_0016020 | Cellular component | membrane |
| GO_0008320 | Molecular function | protein transmembrane transporter activity |
| GO_0038023 | Molecular function | signaling receptor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | SEC63 |
| Protein name | SEC63-like protein isoform 2 SEC63-like (S. cerevisiae) (SEC63-like protein isoform 1) Translocation protein SEC63 homolog SEC63 homolog, protein translocation regulator |
| Synonyms | SEC63L hCG_34021 |
| Description | FUNCTION: Mediates cotranslational and post-translational transport of certain precursor polypeptides across endoplasmic reticulum (ER) . Proposed to play an auxiliary role in recognition of precursors with short and apolar signal peptides. May cooperate with SEC62 and HSPA5/BiP to facilitate targeting of small presecretory proteins into the SEC61 channel-forming translocon complex, triggering channel opening for polypeptide translocation to the ER lumen . Required for efficient PKD1/Polycystin-1 biogenesis and trafficking to the plasma membrane of the primary cilia (By similarity). . |
| Accessions | ENST00000369002.9 Q9UGP8 ENST00000429168.1 F8WB27 A0A0S2Z518 A0A0S2Z5M1 A6PVC9 ENST00000446496.1 |